Principal Investigators

Gary Cutter, PhD, Gil Wolfe, MD

Site-PI

Michael Benatar, MD, PhD

Summary

The purpose of this multi-center, randomized controlled trial is to determine if extended trans-sternal thymectomy combined with prednisone therapy is more beneficial in treating patients with non-thymomatous myasthenia gravis than prednisone alone.

Eligibility criteria

• Generalized myasthenia gravis, onset within last 5 years
• Positive acetylcholine receptor binding antibodies
• Age 18-65
• MGFA class II-IV
• No immunosuppressive therapy other than prednisone for one year
• No thymoma

Funding agency

National Institutes of Health

Collaborators

Gil Wolfe, MD
Gary Cutter, PhD
Henry Kaminski, MD

Project manager

Julie Steele, RN

Alexandra Waltz, MA
Email:
Phone: 305-243-3799

Contact information

Email:
Phone: 305-243-7424

Links

http://www.soph.uab.edu/mgtx/index.htm

Presentations / Publications